Statement of Stockholders' Equity (USD $) In Thousands, except Share data	Total USD ($)	Warrant USD ($)	Common Shares USD ($)	Preferred Stock USD ($)	Series A Preferred Shares	Series A Preferred Shares Preferred Stock	Series B Preferred Shares	Series B Preferred Shares Preferred Stock	Common Shares	Common Shares	Note Receivable USD ($)	Additional paid in capital USD ($)	Additional paid in capital Warrant USD ($)	Additional paid in capital Common Shares USD ($)	Additional paid in capital Preferred Stock USD ($)	Deficit accumulated during development stage USD ($)
Beginning Balance at Nov. 30, 2000
Issuance of stock									825,000
Ending Balance at Jun. 30, 2001									825,000
Beginning Balance at Jun. 30, 2001
Net loss arising during development stage	$ (123)															$ (123)
Issuance of stock									42,050
Issuance of stock	9,022											9,022
Ending Balance at Jun. 30, 2002	8,899											9,022				(123)
Ending Balance at Jun. 30, 2002									867,050
Net loss arising during development stage	(3,033)															(3,033)
Foreign currency translation adjustments	31
Comprehensive loss	(3,002)
Issuance of stock									150
Issuance of stock	36											36
Ending Balance at Jun. 30, 2003	5,933											9,058				(3,156)
Ending Balance at Jun. 30, 2003									867,200
Net loss arising during development stage	(8,538)															(8,538)
Foreign currency translation adjustments	(31)
Comprehensive loss	(8,569)
Issuance of stock									81,767
Issuance of stock	25,578											25,578
Ending Balance at Jun. 30, 2004	22,942											34,636				(11,694)
Ending Balance at Jun. 30, 2004									948,967
Net loss arising during development stage	(6,421)															(6,421)
Comprehensive loss	(6,421)
Ending Balance at Jun. 30, 2005	16,521											34,636				(18,115)
Ending Balance at Jun. 30, 2005									948,967
Net loss arising during development stage	(7,386)															(7,386)
Comprehensive loss	(7,386)
Ending Balance at Jun. 30, 2006	9,135											34,636				(25,501)
Ending Balance at Jun. 30, 2006									948,967
Net loss arising during development stage	(13,820)															(13,820)
Comprehensive loss	(13,820)
Issuance of stock									105,488
Issuance of stock	16,820											16,820
Equity issued as share-based payment (in shares)									2,060
Equity issued as share-based payment	443	1,199										443	1,199
Ending Balance at Jun. 30, 2007	13,777											53,098				(39,321)
Ending Balance at Jun. 30, 2007									1,056,515
Net loss arising during development stage	(12,410)															(12,410)
Comprehensive loss	(12,410)
Issuance of stock									91,067
Issuance of stock	14,727											14,727
Share-based compensation expense	441											441
Ending Balance at Jun. 30, 2008	16,535											68,266				(51,731)
Ending Balance at Jun. 30, 2008									1,147,582
Net loss arising during development stage	(11,180)															(11,180)
Comprehensive loss	(11,180)
Issuance of stock									76,805
Issuance of stock	9,768											9,768
Share-based compensation expense	90											90
Ending Balance at Jun. 30, 2009	15,213											78,124				(62,911)
Ending Balance at Jun. 30, 2009									1,224,387
Net loss arising during development stage	(7,896)															(7,896)
Comprehensive loss	(7,896)
Share-based compensation expense	64											64
Ending Balance at Jun. 30, 2010	7,381											78,188				(70,807)
Ending Balance at Jun. 30, 2010									1,224,387
Net loss arising during development stage	(6,781)															(6,781)
Comprehensive loss	(6,781)
Issuance of common stock for note receivable (in shares)									107,391
Issuance of common stock for note receivable											(1,002)	1,002
Issuance of stock						1,000		742		148,403
Issuance of stock			45	665										45	665
Redemption of preferred stock for cancellation of note receivable (in shares)							(742)
Redemption of preferred stock for cancellation of note receivable											1,002	(1,002)
Share-based compensation expense	484											484
Ending Balance at Jun. 30, 2011	1,794											79,382				(77,588)
Ending Balance at Jun. 30, 2011					1,000				1,480,181
Net loss arising during development stage	(7,523)															(7,523)
Comprehensive loss	(7,523)
Issuance of stock									1,936,310
Issuance of stock	9,831											9,831
Amendment of warrant terms	(14)											(14)
Share-based compensation expense	511											511
Ending Balance at Jun. 30, 2012	4,599											89,710				(85,111)
Ending Balance at Jun. 30, 2012					1,000				3,416,491
Net loss arising during development stage	(11,186)															(11,186)
Comprehensive loss	(11,186)
Issuance of stock									12,699,824
Issuance of stock	39,453											39,453
Conversion of Series A preferred stock					(1,000)				804,500
Issuance of common stock for purchase of intangible assets (in shares)									195,756
Issuance of common stock for purchase of intangible assets	500											500
Share-based compensation expense	1,506											1,506
Ending Balance at Jun. 30, 2013	$ 34,872											$ 131,169				$ (96,297)
Ending Balance at Jun. 30, 2013									17,116,571